莱斯康制药 | 1.23 +0.05 +4.24% | ||
| LXRX | |||
| 高 1.27 | 开 1.20 | 量 208.59万股 | 总市值 4.86亿 |
| 低 1.20 | 换 0.53% | 额 258.30万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
莱斯康制药(LXRX)
01-30 19:15
$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-030233 Act: 34 Size: 21 KB 网页链接
莱斯康制药(LXRX)
02-03 10:55
$莱斯康制药(LXRX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-26-034176 Act: 34 Size: 399 KB 网页链接
莱斯康制药(LXRX)
01-30 05:47
$莱斯康制药(LXRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-029498 Act: 33 Size: 457 KB 网页链接
莱斯康制药(LXRX)
02-03 01:15
$莱斯康制药(LXRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-033160 Act: 33 Size: 460 KB 网页链接
莱斯康制药(LXRX)
7小时前
$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-041416 Act: 34 Size: 20 KB 网页链接
莱斯康制药(LXRX)
2025-11-11 05:35
$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-274383 Act: 34 Size: 137 KB 网页链接
莱斯康制药(LXRX)
01-30 19:16
$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-029894 Act: 34 Size: 19 KB 网页链接
莱斯康制药(LXRX)
02-05 05:35
$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-037644 Size: 59 KB 网页链接
莱斯康制药(LXRX)
01-30 05:46
$莱斯康制药(LXRX)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-029514 Act: 34 Size: 167 KB 网页链接
莱斯康制药(LXRX)
02-03 05:55
$莱斯康制药(LXRX)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 7.01, and 9.01 Accession Number: 0001193125-26-033793 Act: 34 Size: 731 KB 网页链接